Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Negative allosteric modulation of CB1 cannabinoid receptor signalling decreases intravenous morphine self‐administration and relapse in mice

Addiction Biology(2024)10.1111/adb.13429Source: DataRank Database

Negative allosteric modulation of CB1 cannabinoid receptor signalling decreases intravenous morphine self‐administration and relapse in mice is a research paper published in Addiction Biology (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: goldTopics (38)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Fezaan Kazi ORCID,Lucas Cantwell,Ganesh A. Thakur ORCID,Jonathon D. Crystal ORCID,Andrea G. Hohmann ORCID

Live enrichment

PubMed:39109814 PMC:PMC11304470

NIH HHS

Grant: DA047858

NIH HHS

Grant: DA009158

NIH HHS

Grant: EY024717

NEI NIH HHS

Grant: R01 EY024717

NIDA NIH HHS

Grant: P01 DA009158

NIDA NIH HHS

Grant: R01 DA047858

National Institutes of Health

Grant: 5P01DA009158-14

Endocannabinoid Active Sites as Therapeutic Targets

National Institutes of Health

Grant: 5R01EY024717-03

A Novel Pharmacotherapy for Glaucoma

National Institutes of Health

Grant: 1R01DA047858-01

CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence

goldLicense: cc-by

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/adb.13429

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11304470/pdf/ADB-29-e13429.pdf

Europe_PMChttps://europepmc.org/articles/PMC11304470

Europe_PMChttps://europepmc.org/articles/PMC11304470?pdf=render

https://doi.org/10.1111/adb.13429

Fields of Study

03 medical and health sciences0305 other medical science

MeSH Terms

AnimalsMiceRecurrenceMorphineReceptor, Cannabinoid, CB1Analgesics, OpioidSelf AdministrationMotivationConditioning, OperantSignal TransductionAllosteric RegulationMaleDrug-Seeking BehaviorAdministration, IntravenousReinforcement, Psychology

Keywords

MorphineReinforcementOpioidsMotivationCannabinoid Receptor 1Negative Allosteric ModulatorSelf‐administrationMaleDrug-Seeking BehaviorSelf AdministrationAnalgesics, OpioidMiceReceptor, Cannabinoid, CB1Allosteric RegulationRecurrenceAnimalsConditioning, OperantOriginal ArticleAdministration, IntravenousReinforcement, PsychologySignal Transduction

Sustainable Development Goals

SDG 3: 3. Good health

Negative allosteric modulation of CB1 cannabinoid receptor signalling decreases intravenous morphine self‐administration and relapse in mice

FAIR Checklist

Authors (6)

Funding (9 grants)

Open Access

Topics

Annotations (Europe PMC)